Experience

• • ICG in the formation of ICG LP Secondaries I, a $1 billion fund specializing in acquiring buyout fund interests from limited partners.
  • Glendower Capital in the formation of its Secondary Opportunities Fund V, a $5.8 billion global secondary private equity fund.
  • Rithm in its acquisition of Sculptor Capital Management, a multi-strategy hedge fund manager, in a transaction valued at approximately $639 million.
  • LCM Partners in the formation of Credit Opportunities 4 Strategy, a €4.1 billion private credit fund.
  • KKR in the formation of its KKR European Fund VI, an $8 billion fund focused on private equity investments primarily in the developed economies of Western Europe.
  • All Seas Capital in the formation of All Seas Capital I, a $400 million debut pan-European private fund.
  • Tristan Capital, the pan-European real estate investment manager, in its sale of a 31% interest in Tristan to Candriam, a New York Life affiliate, taking Candriam’s total stake in Tristan to 80%.
  • Clayton, Dubilier & Rice in the financing aspects of its acquisitions of Atalian and OCS to create a global facilities management platform.
  • Apera Asset Management in the formation of Apera Private Debt Fund II, a €1.27 billion pan-European mid-market private debt fund.
  • Carlyle in its acquisition of Abingworth, a transatlantic life sciences investment firm with over $2 billion in assets under management.
  • FitzWalter Capital in the formation of FitzWalter Capital Partners I, its $920 million inaugural fund.
  • Fifth Wall in the formation of its European Real Estate Technology Fund, a €140 million fund targeting investments in high-potential European startups, and potential co-investing opportunities alongside Fifth Wall’s North American Real Estate Tech funds.
  • Mizuho, a leading global bank, in its acquisition of Capstone Partners, a leading middle-market placement agent.
  • Canopius, a Centerbridge Partners portfolio company and a leading global specialty (re)insurer, in its $780 million loss portfolio transfer agreement with RiverStone International.
  • EQT in funds and regulatory aspects of its €450 million acquisition of Life Sciences Partners, a leading European life sciences venture capital firm.
  • CANDRIAM and its affiliate New York Life Investments Alternatives in their strategic partnership with Kartesia Management, a private credit manager, and the related acquisition of a minority stake in the firm.
  • LGT Capital Partners in the formation of Crown Global Secondaries V, a $4.5 billion private equity secondaries fund.